CARSGEN-B News

CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 7 17:33

CARSGEN-B: Notification Letter and Reply Form to Registered Shareholders

Apr 30 22:14

CARSGEN-B: Notification Letter and Reply Form to Non-registered Shareholders

Apr 30 22:09

CARSGEN-B: REVISED FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING

Apr 30 22:03

CARSGEN-B: VOLUNTARY ANNOUNCEMENT - ABSTRACTS FROM THE ONGOING STUDIES OF ZEVORCABTAGENE AUTOLEUCEL AND CT071 ARE TO BE PRESENTED AS AN ORAL PRESENTATION AND A POSTER PRESENTATION, RESPECTIVELY, AT THE UPCOMING EHA 2024

Apr 30 08:00

CARSGEN-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Apr 29 22:40

CARSGEN-B: (1) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (3) CHANGE IN THE COMPOSITION OF BOARD COMMITTEES

Apr 29 22:38

CARSGEN-B: VOLUNTARY ANNOUNCEMENT - CMC RESPONSES TO FDA OBSERVATIONS SUBMITTED

Apr 29 08:00

CARSGEN-B: Notification Letter and Reply Form to Registered Shareholders

Apr 18 17:23

CARSGEN-B: Notification Letter and Reply Form to Non-registered Shareholders

Apr 18 17:16

CARSGEN-B: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING

Apr 18 17:07

CARSGEN-B: VOLUNTARY ANNOUNCEMENT - ORAL PRESENTATION OF RESEARCH UPDATES ON SATRICABTAGENE AUTOLEUCEL AT 2024 ASCO ANNUAL MEETING

Apr 11 18:25

CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 8 18:53

CARSGEN-B: PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE EIGHTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

Mar 26 19:37

CARSGEN-B: Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Mar 18 16:36

CARSGEN-B: Letter to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Mar 18 16:34

CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 6 20:06

CARSGEN-B: INSIDE INFORMATION ANNOUNCEMENT - THE NMPA APPROVES THE BCMA CAR-T THERAPY ZEVORCABTAGENE AUTOLEUCEL FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA WHO HAVE PROGRESSED AFTER AT LEAST 3 PRIOR LINES OF THERAPY (I

Mar 1 12:26

CARSGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 6 19:32

CARSGEN-B: VOLUNTARY ANNOUNCEMENT - UPDATED RESEARCH RESULTS ON CT041 AT 2024 ASCO GI MEETING

Jan 19 08:00